China Automotive Systems Reports 77.8% EPS Growth in the Third Quarter of 2025 and Raises Full Year Guidance

Stock Information for Opiant Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Opiant Pharmaceuticals Inc.

China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
China Automotive Systems Signs Strategic Cooperation MoU With KYB-UMW to Advance High-End Manufacturing in Malaysia and Further Develop ASEAN Market
CAAS Introduces Rear-Wheel Active Steering Technology to Upper Mass-Market EVs in China
CHINA AUTOMOTIVE SYSTEMS COMPLETES REDOMICILIATION MERGER
China Automotive Systems Announces Special Meeting of Stockholders on September 10, 2025
China Automotive Systems Reports Income From Operations Increased by 20.2% in the Second Quarter of 2025
China Automotive Systems to Announce Unaudited 2025 Second Quarter Financial Results on August 13, 2025
China Automotive Systems Begins Mass Production of First iRCB Compatible L2+ Assisted Driving Systems for China Market

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.